5/9/2025

Stryker's Mako spine and shoulder applications are set to launch soon, potentially boosting its orthopedics and spine businesses. Click to read why SYK is a Hold.

Source: SeekingAlpha

5/9/2025

We recently published a list of 11 Best Medical Device Stocks to Buy Now. In this article, we are going to take a look at where Zimmer Biomet Holdings, Inc. (NYSE:ZBH) stands against other best medical device stocks to buy now. Trump’s Tariffs Are Dividing the Medical Community On April 16, CNBC reported that Trump’s […]

Source: Yahoo

5/8/2025

Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day

Source: MarketWatch

5/6/2025

Zimmer Biomet Holdings (NYSE:ZBH) recently reported solid financial performance, with increased sales and net income for the first quarter of 2025, along with a raised earnings guidance for the year. Despite these positive results, the company's stock price fell 11% over the past week. This decline came amid a broader market downturn, with stocks slipping as investors awaited news on tariffs and Federal Reserve decisions. While Zimmer Biomet's financial updates were strong, they were not...

Source: Yahoo

5/6/2025

Zimmer Biomet expects that the majority of tariff impact on profits will be incurred in the second half of the year.

Source: Yahoo

5/6/2025

Zimmer Biomet Holdings ( NYSE:ZBH ) First Quarter 2025 Results Key Financial Results Revenue: US$1.91b (up 1.1% from 1Q...

Source: Yahoo

5/6/2025

The orthopedics company lowered its earnings forecast, accounting for the tariffs and closing the acquisition of Paragon 28.

Source: Yahoo

5/6/2025

Zimmer Biomet's stock drops 10% after weak Q1 results.

Source: SeekingAlpha

5/6/2025

Zimmer Biomet Holdings Inc (ZBH) reports steady revenue growth and strategic advancements despite facing tariff headwinds and adjusted EPS guidance revisions.

Source: Yahoo

5/6/2025

Q1 2025 Zimmer Biomet Holdings Inc Earnings Call

Source: Yahoo

5/5/2025

The S&P 500 slipped 0.6% on Monday, May 5, 2025, breaking a nine-day winning streak ahead of this week's interest-rate decision by the Federal Open Market Committee.

Source: Yahoo

5/5/2025

Shares of medical device company Zimmer Biomet (NYSE:ZBH) fell 10.2% in the afternoon session after the company reported underwhelming first quarter 2025 results as it lowered its full-year EPS guidance. A key takeaway was the weak growth. Sales were up just 1% as demand for some product lines came in weaker. While hips and trauma gear did well, others, like bone cement and surgical tools, dropped nearly 5%. Overall, this was a softer quarter.

Source: Yahoo

5/5/2025

Zimmer Biomet reports solid first-quarter performance across its geographic regions. However, contraction in its operating margin is a concern.

Source: Yahoo

5/5/2025

Zimmer Biomet Holdings Inc. stock underperforms Monday when compared to competitors

Source: MarketWatch

5/5/2025

While the top- and bottom-line numbers for Zimmer (ZBH) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Source: Yahoo

5/5/2025

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q1 2025 Earnings Conference Call May 5, 2025 8:30 AM ETCompany ParticipantsDavid DeMartino - SVP, IRIvan Tornos -...

Source: SeekingAlpha

5/5/2025

Earlier this year, Zimmer said that it would acquire medical device firm Paragon 28 for $1.1 billion, to expand its portfolio of orthopedic surgical devices. Zimmer expects 2025 adjusted profit per share in the range of $7.90 to $8.10, compared with its prior view of $8.15 to $8.35 per share. Analysts were expecting annual profit of $8.19 per share, according to data compiled by LSEG.

Source: Yahoo

5/5/2025

Zimmer (ZBH) delivered earnings and revenue surprises of 2.84% and 0.88%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Source: Yahoo

5/5/2025

Zimmer Biomet Holdings onMonday lowered its 2025 adjusted profit forecast, and said itexpects the proposed trade tariffs to weigh on the company'searnings this year. The Warsaw,...

Source: Finnhub

5/5/2025

Medical device company Zimmer Biomet (NYSE:ZBH) announced better-than-expected revenue in Q1 CY2025, with sales up 1.1% year on year to $1.91 billion. Its non-GAAP profit of $1.81 per share was 2.3% above analysts’ consensus estimates.

Source: Yahoo